Autonomy, moral constraints, and markets in kidneys

Area of Science:

• Bioethics
• Medical Law
• Transplantation Ethics

Background:

• A chronic shortage of kidneys for transplantation exists globally.
• Regulated kidney markets are proposed as a solution to increase organ availability.
• The ethical implications of such markets, particularly concerning autonomy and Kantian principles, require careful examination.

Purpose of the Study:

• To evaluate the morality of establishing regulated kidney markets.
• To rebut the argument that intrinsic value of autonomy necessitates support for kidney markets.
• To propose alternative strategies for addressing the organ shortage.

Main Methods:

• Philosophical argumentation, focusing on Kantian ethics.
• Analysis of the concept of human dignity and its relation to organ markets.
• Comparative evaluation of regulated markets versus opt-out systems.

Main Results:

• The article argues against regulated kidney markets, contending they may violate Kantian principles of human dignity and not treating persons as mere means.
• It challenges the view that valuing autonomy inherently supports regulated organ markets.
• Opt-out systems for cadaveric organ donation are presented as a morally preferable alternative.

Conclusions:

• Regulated kidney markets pose moral risks under current conditions.
• Ethical concerns regarding human dignity and instrumentalization outweigh potential benefits of organ markets.
• Opt-out systems offer a more ethically sound approach to increasing organ donation rates.